Zimmer Biomet
Zimmer Biomet Holdings, Inc., commonly referred to as Zimmer Biomet, is a leading global medical device company headquartered in the United States. Founded in 1927, the company has established a strong presence in the orthopaedics and musculoskeletal sectors, focusing on innovative solutions for joint reconstruction, trauma, spine, and dental applications.
With major operational regions across North America, Europe, and Asia-Pacific, Zimmer Biomet is renowned for its advanced products, including joint replacement implants and surgical instruments. The company’s commitment to research and development has led to significant milestones, positioning it as a trusted partner in the healthcare industry. Notably, Zimmer Biomet's unique offerings, such as personalised surgical solutions and cutting-edge robotic technologies, enhance patient outcomes and streamline surgical procedures, solidifying its market leadership.
+10 vs industry average
Zimmer Biomet’s score of 39 is higher than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Zimmer Biomet?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Medical Device Manufacturing has below-average carbon intensity
Industry performance
The Medical Device Manufacturing industry has reduced its overall emissions by 32% since 2018
Emissions trajectory 2020 – 2028
Reported emissions
Scope 3 accounts for ••• of total emissions.
Zimmer Biomet's reported carbon emissions
In 2025, Zimmer Biomet reported total greenhouse gas emissions of approximately 37,195,000 kg CO2e, comprising 15,094,000 kg CO2e from Scope 1 and 22,101,000 kg CO2e from Scope 2 emissions. The company has set ambitious climate commitments, aiming to reduce its absolute Scope 1 and 2 emissions by 55% by 2030, using a 2017 baseline. Additionally, Zimmer Biomet has pledged to achieve net-zero greenhouse gas emissions by 2050, formalised in September 2023 in collaboration with the Science Based Targets initiative (SBTi).
The company also aims to reduce its Scope 3 emissions from purchased goods and services by 15% by 2030, based on a 2019 baseline. These targets reflect Zimmer Biomet's commitment to align with industry standards for climate action and contribute to global efforts to mitigate climate change.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Zimmer Biomet’s Climate Goals (2030 & 2050)
3 goals2030
55% reduction in Scope 1
Zimmer Biomet commits to reduce absolute scope 1 GHG emissions 55% by 2030 from a 2017 base year.
2030
55% reduction in Scope 2
Zimmer Biomet commits to reduce absolute scope 2 GHG emissions 55% by 2030 from a 2017 base year.
2030
15% reduction in scope 3 upstream
Zimmer Biomet also commits to reduce absolute scope 3 GHG emissions from purchased goods and services 15% by 2030 from a 2019 base year.
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Zimmer Biomet
Frequently asked questions
Common questions about Zimmer Biomet’s sustainability data and climate commitments
Data year: 2025
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project